State of the Art Interdisciplinary Management of Prostate Cancer VL

The Use of Radioligand Treatments in Metastatic Castration-Resistant Prostate Cancer - Matthew Abramowitz

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Matthew Abramowitz, MD, Associate Professor, Department of Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL Rana McKay, MD , Medical Oncologist, Associate Profe...

Case-Based Discussion on Navigating the Evolving Landscape of Castrate-Resistant Prostate Cancer Management - Oliver Sartor

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A. Oliver Sartor, MD, Professor of Medicine, Urology, and Radiology, Director Radiopharmaceutical Trials, Mayo Clinic, Rochester, MN Rana McKay, MD , Medical Oncologist, Associate Professor of Medicine...

Advances in Staging and Personalized Radiation Therapy for High-Risk Localized Prostate Cancer - Leslie Ballas

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Leslie Ballas, MD , Radiation Oncologist, Cedars-Sinai Medical Center, Los Angeles, CA Rana McKay, MD , Medical Oncologist, Associate Professor of Medicine, UC San Diego School of Medicine, San Diego,...

An Overview of Treatment Strategies in Localized Prostate Cancer: From Active Surveillance to Intensive Therapy - Neal Shore

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology Clinics, Chief Medical Officer, Surgery/Urology, for GenesisCare, US, Myrtle Beach, SC Rana McKay, MD, Med...

An Overview of Strategies and Therapeutic Advances in Metastatic Prostate Cancer - Rana McKay

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana McKay, MD, Medical Oncologist, Associate Professor of Medicine, UC San Diego School of Medicine, San Diego, CA Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlanti...

Advances and Challenges in High-Risk CSPC: A Multidisciplinary Approach to Patient Management - Paul Sieber

Details
State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER US LLC PHARMACEUTICALS Biographies: Paul Sieber, MD, FACS, Medical Director for Clinical Trials, Keystone Urology Specialists, Lancaster, PA Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology Clinics, Chi...

Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer - Alan Bryce

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan Bryce, MD, Chief Clinical Officer, City of Hope Cancer Center Pheonix, Phoenix, Arizona Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre, Madrid, Spain Related Content: An Overview in t...

Optimizing Treatment in Metastatic Hormone-Sensitive Prostate Cancer: A Case Study Analysis - Alicia Morgans

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farber Cancer Institute, Boston, Massachusetts Elena Castro, MD, PhD, Hospital Universitario...

PSMA PET Imaging and Targeted Therapies: A Case Study on High-Risk Localized Prostate Cancer - Tian Zhang

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Tian Zhang, MD, MHS, Associate Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre, Madri...

The Use of Imaging in Staging Localized Prostate Cancer: A Case Study on High-Risk Localized Prostate Cancer - Zachary Klaassen

Details
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Zachary Klaassen, MD, MSc, Urologic Oncologist, Assistant Professor Surgery/Urology at the Medical College of Georgia at Augusta University, Well Star MCG, Georgia Cancer Center, Augusta, GA Neal D. Sh...